Supernus Pharmaceuticals, Inc.

8-K Other events Aug 3, 2026 8-K Other events Aug 3, 2026 10-Q Quarter ended 2026-06-30 Aug 3, 2026 8-K Results of operations (earnings release) Aug 3, 2026 8-K Entered a material agreement; Director or officer change; Other events Aug 3, 2026 8-K Results of operations (earnings release) Jul 22, 2026 8-K Shareholder vote results Jun 18, 2026 8-K Took on a direct financial obligation May 20, 2026 10-Q Quarter ended 2026-03-31 May 5, 2026 8-K Results of operations (earnings release) May 5, 2026 8-K Results of operations (earnings release) Apr 22, 2026 8-K Entered a material agreement; Completed an acquisition or disposition Apr 7, 2026 10-K Fiscal year ended 2025-12-31 Mar 2, 2026 8-K Director or officer change Feb 24, 2026 8-K Results of operations (earnings release) Feb 24, 2026 8-K Results of operations (earnings release) Feb 12, 2026 8-K Jan 28, 2026 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release); Regulation FD disclosure Nov 4, 2025 8-K Results of operations (earnings release) Oct 21, 2025 8-K/A 8-K Oct 16, 2025 10-Q Quarter ended 2025-06-30 Aug 5, 2025 8-K Results of operations (earnings release) Aug 5, 2025 8-K Director or officer change Aug 4, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Other events Jul 31, 2025 8-K Results of operations (earnings release) Jul 22, 2025 8-K Shareholder vote results Jun 17, 2025 8-K Entered a material agreement; Other events Jun 16, 2025 8-K Other events May 28, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 8-K Results of operations (earnings release) Apr 23, 2025 10-K Fiscal year ended 2024-12-31 Feb 25, 2025 8-K Results of operations (earnings release) Feb 25, 2025 8-K Director or officer change Feb 24, 2025 8-K Other events Feb 18, 2025 8-K Results of operations (earnings release) Feb 11, 2025 8-K Other events Feb 4, 2025 8-K Other events Jan 27, 2025 8-K Item 5.05 Dec 20, 2024